ANT-308

N/A

Report date: 2025/03/05 16:02:13
NME

Base Information

Drug NameANT-308
Drug Alias NameANT-308ANT308
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVasoactive intestinal peptide receptor antagonists
TargetsVasoactive intestinal peptide receptor
Therapy Area/IndicationsCarcinoma, Pancreatic DuctalLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCambium Oncology LLC
China Registration ClassN/A

Develop Information

Active CompaniesCambium Oncology LLCOrient Europharma Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Pancreatic DuctalLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A